Carregant...

Ligandomics: a paradigm shift in biological drug discovery

As productivity of pharmaceutical research and development (R&D) for small-molecule drugs declines, the trend in drug discovery strategies is shifting towards biologics, which predominantly target secreted or cell surface proteins. Receptors and ligands are the most-valuable drug targets. In con...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drug Discov Today
Autors principals: Li, Wei, Pang, Iok-Hou, Pacheco, Mario Thiego F., Tian, Hong
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5849512/
https://ncbi.nlm.nih.gov/pubmed/29326083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2018.01.013
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!